259 related articles for article (PubMed ID: 25989018)
1. Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.
Strobl AN; Vickers AJ; Van Calster B; Steyerberg E; Leach RJ; Thompson IM; Ankerst DP
J Biomed Inform; 2015 Aug; 56():87-93. PubMed ID: 25989018
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Ankerst DP; Boeck A; Freedland SJ; Thompson IM; Cronin AM; Roobol MJ; Hugosson J; Stephen Jones J; Kattan MW; Klein EA; Hamdy F; Neal D; Donovan J; Parekh DJ; Klocker H; Horninger W; Benchikh A; Salama G; Villers A; Moreira DM; Schröder FH; Lilja H; Vickers AJ
World J Urol; 2012 Apr; 30(2):181-7. PubMed ID: 22210512
[TBL] [Abstract][Full Text] [Related]
3. The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator.
Ankerst DP; Till C; Boeck A; Goodman P; Tangen CM; Feng Z; Partin AW; Chan DW; Sokoll L; Kagan J; Wei JT; Thompson IM
J Urol; 2013 Jul; 190(1):70-6. PubMed ID: 23313212
[TBL] [Abstract][Full Text] [Related]
4. Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort.
Park JY; Yoon S; Park MS; Choi H; Bae JH; Moon DG; Hong SK; Lee SE; Park C; Byun SS
PLoS One; 2017; 12(1):e0168917. PubMed ID: 28046017
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan.
Auffenberg GB; Merdan S; Miller DC; Singh K; Stockton BR; Ghani KR; Denton BT
Urology; 2017 Jun; 104():137-142. PubMed ID: 28237530
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer risk prediction in a urology clinic in Mexico.
Liang Y; Messer JC; Louden C; Jimenez-Rios MA; Thompson IM; Camarena-Reynoso HR
Urol Oncol; 2013 Oct; 31(7):1085-92. PubMed ID: 22306115
[TBL] [Abstract][Full Text] [Related]
7. The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.
Strobl AN; Thompson IM; Vickers AJ; Ankerst DP
J Urol; 2015 Jul; 194(1):58-64. PubMed ID: 25636656
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort.
Trottier G; Roobol MJ; Lawrentschuk N; Boström PJ; Fernandes KA; Finelli A; Chadwick K; Evans A; van der Kwast TH; Toi A; Zlotta AR; Fleshner NE
BJU Int; 2011 Oct; 108(8 Pt 2):E237-44. PubMed ID: 21507190
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Ankerst DP; Boeck A; Freedland SJ; Jones JS; Cronin AM; Roobol MJ; Hugosson J; Kattan MW; Klein EA; Hamdy F; Neal D; Donovan J; Parekh DJ; Klocker H; Horninger W; Benchikh A; Salama G; Villers A; Moreira DM; Schröder FH; Lilja H; Vickers AJ; Thompson IM
World J Urol; 2014 Feb; 32(1):185-91. PubMed ID: 22527674
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort.
Poyet C; Nieboer D; Bhindi B; Kulkarni GS; Wiederkehr C; Wettstein MS; Largo R; Wild P; Sulser T; Hermanns T
BJU Int; 2016 Mar; 117(3):401-8. PubMed ID: 26332503
[TBL] [Abstract][Full Text] [Related]
12. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
Nguyen CT; Yu C; Moussa A; Kattan MW; Jones JS
J Urol; 2010 Feb; 183(2):529-33. PubMed ID: 20006887
[TBL] [Abstract][Full Text] [Related]
13. The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting.
Liang Y; Ankerst DP; Feng Z; Fu R; Stanford JL; Thompson IM
Urol Oncol; 2013 Nov; 31(8):1464-9. PubMed ID: 22552047
[TBL] [Abstract][Full Text] [Related]
14. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
Nam RK; Kattan MW; Chin JL; Trachtenberg J; Singal R; Rendon R; Klotz LH; Sugar L; Sherman C; Izawa J; Bell D; Stanimirovic A; Venkateswaran V; Diamandis EP; Yu C; Loblaw DA; Narod SA
J Clin Oncol; 2011 Aug; 29(22):2959-64. PubMed ID: 21690464
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
Parekh DJ; Ankerst DP; Higgins BA; Hernandez J; Canby-Hagino E; Brand T; Troyer DA; Leach RJ; Thompson IM
Urology; 2006 Dec; 68(6):1152-5. PubMed ID: 17169636
[TBL] [Abstract][Full Text] [Related]
17. A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.
Roobol MJ; Zhu X; Schröder FH; van Leenders GJ; van Schaik RH; Bangma CH; Steyerberg EW
Eur Urol; 2013 Apr; 63(4):627-33. PubMed ID: 22841675
[TBL] [Abstract][Full Text] [Related]
18. Compliance with biopsy recommendations of a prostate cancer risk calculator.
van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
[TBL] [Abstract][Full Text] [Related]
19. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: recent trends in Korea.
Chi BH; Chang IH
Urol Int; 2010; 85(1):88-93. PubMed ID: 20616537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
